Bacil Pharma Statistics

Total Valuation

Bacil Pharma has a market cap or net worth of INR 176.54 million. The enterprise value is 170.86 million.

Market Cap	176.54M
Enterprise Value	170.86M

Important Dates

The last earnings date was Wednesday, August 12, 2026.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Bacil Pharma has 14.35 million shares outstanding.

Current Share Class	14.35M
Shares Outstanding	14.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.36%
Owned by Institutions (%)	n/a
Float	6.06M

Valuation Ratios

The trailing PE ratio is 20.28.

PE Ratio	20.28
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.71
P/TBV Ratio	0.71
P/FCF Ratio	24.81
P/OCF Ratio	24.81
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	19.63
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	24.01

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-4.42%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.60%
Revenue Per Employee	n/a
Profits Per Employee	4.35M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-7.08M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.20% in the last 52 weeks. The beta is 0.43, so Bacil Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-67.20%
50-Day Moving Average	29.80
200-Day Moving Average	41.36
Relative Strength Index (RSI)	12.82
Average Volume (20 Days)	113,176

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.59M
Pretax Income	1.63M
Net Income	8.70M
EBITDA	n/a
EBIT	-1.59M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 5.69 million in cash and no debt, with a net cash position of 5.69 million or 0.40 per share.

Cash & Cash Equivalents	5.69M
Total Debt	n/a
Net Cash	5.69M
Net Cash Per Share	0.40
Equity (Book Value)	248.13M
Book Value Per Share	17.56
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	7.12M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	7.12M
FCF Per Share	0.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bacil Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	4.93%
FCF Yield	4.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2